Down-regulation of gp63 level in Leishmania amazonensis promastigotes reduces their infectivity in BALB/c mice

Microbes and Infection

Volumn 8, Issue 6, 2006, Pages 1455-1463

  Thiakaki, Maria ^a   Kolli, Bala ^b   Chang, Kwang Poo ^b   Soteriadou, Ketty ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

BALB c mice; Down regulation; gp63; Infectivity; Leishmania amazonensis; Mutants; Up regulation

Indexed keywords

GAMMA INTERFERON; GLYCOPROTEIN; GLYCOPROTEIN GP 63; INTERLEUKIN 10; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; DOWN REGULATION; FEMALE; IMMUNE RESPONSE; IN VIVO STUDY; INOCULATION; LEISHMANIA; LYMPH NODE; LYSIS; MACROPHAGE; MOUSE; NONHUMAN; PARASITE; PRIORITY JOURNAL; PROMASTIGOTE; PROTOZOAL INFECTION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; DOWN-REGULATION; EAR; FEMALE; FLOW CYTOMETRY; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; LYMPH NODES; METALLOENDOPEPTIDASES; MICE; MICE, INBRED BALB C; SPECIFIC PATHOGEN-FREE ORGANISMS; T-LYMPHOCYTE SUBSETS; TRANSFECTION;

LEISHMANIA AMAZONENSIS;

EID: 33745154201     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2006.01.006     Document Type: Article

References (31)

1. Chang K.P., Chaudhuri G., and Fong D. Molecular determinants of Leishmania virulence. Annu. Rev. Microbiol. 44 (1990) 499-529
2. Chang K.P., and McGwire B.S. Molecular determinants and regulation of Leishmania virulence. Kinetoplastid Biol. Dis. 1 (2002) 1
3. Turco S.J., Spath G.F., and Beverley S.M. Is lipophosphoglycan a virulence factor? A surprising diversity between Leishmania species. Trends. Parasitol. 17 (2001) 223-226
4. Chaudhuri G., Chaudhuri M., Pan A., and Chang K.P. Surface acid proteinase (gp63) of Leishmania mexicana. A metalloenzyme capable of protecting liposome-encapsulated proteins from phagolysosomal degradation by macrophages. J. Biol. Chem. 264 (1989) 7483-7489
5. Russell D.G. Leishmania and the macrophage. Immunol. Today 11 (1990) 74-75
6. Bouvier J., Schneider P., and Etges R. Leishmanolysin: surface metalloproteinase of Leishmania. Methods Enzymol. 248 (1995) 614-633
7. Brittingham A., Morrison C.J., McMaster W.R., McGwire B.S., Chang K.P., and Mosser D.M. Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. J. Immunol. 155 (1995) 3102-3111
8. Wilson M.E., Hardin K.K., and Donelson J.E. Expression of the major surface glycoprotein of Leishmania donovani chagasi in virulent and attenuated promastigotes. J. Immunol. 143 (1989) 678-684
9. Kink J.A., and Chang K.P. N-glycosylation as a biochemical basis for virulence in Leishmania mexicana amazonensis. Mol. Biochem. Parasitol. 27 (1988) 181-190
10. Liu X., and Chang K.P. Extrachromosomal genetic complementation of surface metalloproteinase (gp63)-deficient Leishmania increases their binding to macrophages. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 4991-4995
11. McGwire B.S., Chang K.P., and Engman D.M. Migration through the extracellular matrix by the parasitic protozoan Leishmania is enhanced by surface metalloprotease gp63. Infect. Immun. 71 (2003) 1008-1010
12. Joshi P.B., Kelly B.L., Kamhawi S., Sacks D.L., and McMaster W.R. Targeted gene deletion in Leishmania major identifies leishmanolysin (GP63) as a virulence factor. Mol. Biochem. Parasitol. 120 (2002) 33-40
13. McMahon-Pratt D., and Alexander J. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?. Immunol. Rev. 201 (2004) 206-224
14. Afonso L.C., and Scott P. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect. Immun. 61 (1993) 2952-2959
15. Jones D.E., Buxbaum L.U., and Scott P. IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection. J. Immunol. 165 (2000) 364-372
16. Soong L., Chang C.H., Sun J., Longley Jr. B.J., Ruddle N.H., Flavell R.A., and McMahon-Pratt D. Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection. J. Immunol. 158 (1997) 5374-5383
17. Chen D.Q., Kolli B.K., Yadava N., Lu H.G., Gilman-Sachs A., Peterson D.A., and Chang K.P. Episomal expression of specific sense and antisense mRNAs in Leishmania amazonensis: modulation of gp63 level in promastigotes and their infection of macrophages in vitro. Infect. Immun. 68 (2000) 80-86
18. Bisti S., Konidou G., Papageorgiou F., Milon G., Boelaert J.R., and Soteriadou K. The outcome of Leishmania major experimental infection in BALB/c mice can be modulated by exogenously delivered iron. Eur. J. Immunol. 30 (2000) 3732-3740
19. Thiakaki M., Rohousova I., Volfova V., Volf P., Chang K.P., and Soteriadou K. Sand fly specificity of saliva-mediated protective immunity in Leishmania amazonensis-BALB/c mouse model. Microbes Infect. 7 (2005) 760-766
20. Titus R.G., Marchand M., Boon T., and Louis J.A. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol. 7 (1985) 545-555
21. Belkaid Y., Kamhawi S., Modi G., Valenzuela J., Noben-Trauth N., Rowton E., Ribeiro J., and Sacks D.L. Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J. Exp. Med. 188 (1998) 1941-1953
22. Soong L., Xu J.C., Grewal I.S., Kima P., Sun J., Longley Jr. B.J., Ruddle N.H., McMahon-Pratt D., and Flavell R.A. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. Immunity 4 (1996) 263-273
23. Ji J., Sun J., Qi H., and Soong L. Analysis of T helper cell responses during infection with Leishmania amazonensis. Am. J. Trop. Med. Hyg. 66 (2002) 338-345
24. Hajmova M., Chang K.P., Kolli B., and Volf P. Down-regulation of gp63 in Leishmania amazonensis reduces its early development in Lutzomyia longipalpis. Microbes Infect. 6 (2004) 646-649
25. Spath G.F., Garraway L.A., Turco S.J., and Beverley S.M. The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 9536-9541
26. Cruz A.K., Titus R., and Beverley S.M. Plasticity in chromosome number and testing of essential genes in Leishmania by targeting. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 1599-1603
27. Kima P.E., Constant S.L., Hannum L., Colmenares M., Lee K.S., Haberman A.M., Shlomchik M.J., and McMahon-Pratt D. Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J. Exp. Med. 191 (2000) 1063-1068
28. Ji J., Sun J., and Soong L. Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis. Infect. Immun. 71 (2003) 4278-4288
29. Buxbaum L.U., Uzonna J.E., Goldschmidt M.H., and Scott P. Control of New World cutaneous leishmaniasis is IL-12 independent but STAT4 dependent. Eur. J. Immunol. 32 (2002) 3206-3215
30. Padigel U.M., Alexander J., and Farrell J.P. The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis. J. Immunol. 171 (2003) 3705-3710
31. Courret N., Lang T., Milon G., and Antoine J.C. Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice. Int. J. Parasitol. 33 (2003) 1373-1383